Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 607

1.

Magnetic field compatible circuit quantum electrodynamics with graphene Josephson junctions.

Kroll JG, Uilhoorn W, van der Enden KL, de Jong D, Watanabe K, Taniguchi T, Goswami S, Cassidy MC, Kouwenhoven LP.

Nat Commun. 2018 Nov 5;9(1):4615. doi: 10.1038/s41467-018-07124-x.

2.

Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.

Bosman KJ, Wensing AM, Pijning AE, van Snippenberg WJ, van Ham PM, de Jong DM, Hoepelman AI, Nijhuis M.

J Int AIDS Soc. 2018 Sep;21(9):e25185. doi: 10.1002/jia2.25185.

3.

Differences in the morphology, physiology and gene expression of honey bee queens and workers reared in vitro versus in situ.

De Souza DA, Kaftanoglu O, De Jong D, Page RE, Amdam GV, Wang Y.

Biol Open. 2018 Oct 25. pii: bio.036616. doi: 10.1242/bio.036616. [Epub ahead of print]

4.

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.

de Jong DC, Löwenberg M, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Gecse K, Ponsioen CY, D'Haens GR, Irving PM, Samaan MA.

Inflamm Bowel Dis. 2018 Oct 17. doi: 10.1093/ibd/izy325. [Epub ahead of print]

PMID:
30329045
5.

Correction: The landscape of epilepsy-related GATOR1 variants.

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G, Conti V, Guerrini R, Bisulli F, Licchetta L, Pippucci T, Tinuper P, Hirsch E, de Saint Martin A, Chelly J, Rudolf G, Chipaux M, Ferrand-Sorbets S, Dorfmüller G, Sisodiya S, Balestrini S, Schoeler N, Hernandez-Hernandez L, Krithika S, Oegema R, Hagebeuk E, Gunning B, Deckers C, Berghuis B, Wegner I, Niks EH, Jansen FE, Braun K, de Jong D, Rubboli G, Talvik I, Sander V, Uldall P, Jacquemont ML, Nava C, Leguern E, Julia S, Gambardella A, d'Orsi G, Crichiutti G, Faivre L, Darmency V, Benova B, Krsek P, Biraben A, Lebre AS, Jennesson M, Sattar S, Marchal C, NordliJr DR, Lindstrom K, Striano P, Lomax LB, Kiss C, Bartolomei F, Lepine AF, Schoonjans AS, Stouffs K, Jansen A, Panagiotakaki E, Ricard-Mousnier B, Thevenon J, de Bellescize J, Catenoix H, Dorn T, Zenker M, Müller-Schlüter K, Brandt C, Krey I, Polster T, Wolff M, Balci M, Rostasy K, Achaz G, Zacher P, Becher T, Cloppenborg T, Yuskaitis CJ, Weckhuysen S, Poduri A, Lemke JR, Møller RS, Baulac S.

Genet Med. 2018 Sep 27. doi: 10.1038/s41436-018-0325-9. [Epub ahead of print]

PMID:
30262923
6.

MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.

Yuan Y, Niu F, Nolte IM, Koerts J, de Jong D, Rutgers B, Osinga J, Azkanaz M, Terpstra M, Bystrykh L, Diepstra A, Visser L, Dzikiewicz-Krawczyk A, Kok K, Kluiver J, van den Berg A.

Cell Physiol Biochem. 2018;49(1):144-159. doi: 10.1159/000492850. Epub 2018 Sep 5.

7.

The landscape of epilepsy-related GATOR1 variants.

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G, Conti V, Guerrini R, Bisulli F, Licchetta L, Pippucci T, Tinuper P, Hirsch E, de Saint Martin A, Chelly J, Rudolf G, Chipaux M, Ferrand-Sorbets S, Dorfmüller G, Sisodiya S, Balestrini S, Schoeler N, Hernandez-Hernandez L, Krithika S, Oegema R, Hagebeuk E, Gunning B, Deckers C, Berghuis B, Wegner I, Niks E, Jansen FE, Braun K, de Jong D, Rubboli G, Talvik I, Sander V, Uldall P, Jacquemont ML, Nava C, Leguern E, Julia S, Gambardella A, d'Orsi G, Crichiutti G, Faivre L, Darmency V, Benova B, Krsek P, Biraben A, Lebre AS, Jennesson M, Sattar S, Marchal C, Nordli DR Jr, Lindstrom K, Striano P, Lomax LB, Kiss C, Bartolomei F, Lepine AF, Schoonjans AS, Stouffs K, Jansen A, Panagiotakaki E, Ricard-Mousnier B, Thevenon J, de Bellescize J, Catenoix H, Dorn T, Zenker M, Müller-Schlüter K, Brandt C, Krey I, Polster T, Wolff M, Balci M, Rostasy K, Achaz G, Zacher P, Becher T, Cloppenborg T, Yuskaitis CJ, Weckhuysen S, Poduri A, Lemke JR, Møller RS, Baulac S.

Genet Med. 2018 Aug 10. doi: 10.1038/s41436-018-0060-2. [Epub ahead of print] Erratum in: Genet Med. 2018 Aug 29;:. Genet Med. 2018 Sep 27;:.

PMID:
30093711
8.

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D.

Blood. 2018 Nov 1;132(18):1871-1878. doi: 10.1182/blood-2018-04-842559. Epub 2018 Aug 6. Review.

PMID:
30082493
9.

Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply.

de Jong D, de Boer M, van Leeuwen FE.

JAMA Oncol. 2018 Oct 1;4(10):1435. doi: 10.1001/jamaoncol.2018.2624. No abstract available.

PMID:
30054614
10.

Living in the intertidal: desiccation and shading reduce seagrass growth, but high salinity or population of origin have no additional effect.

Suykerbuyk W, Govers LL, van Oven WG, Giesen K, Giesen WBJT, de Jong DJ, Bouma TJ, van Katwijk MM.

PeerJ. 2018 Jul 20;6:e5234. doi: 10.7717/peerj.5234. eCollection 2018.

11.

Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants.

de Boer M, Hauptmann M, de Jong D, van Leeuwen FE, Rakhorst HA, van der Hulst RRWJ.

Plast Reconstr Surg. 2018 Oct;142(4):590e-591e. doi: 10.1097/PRS.0000000000004783. No abstract available.

PMID:
30036331
12.

Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod.

de Jong BA, van Kempen ZLE, Wattjes MP, Smit PM, Peferoen L, Berry D, Chamuleau MED, de Jong D.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e483. doi: 10.1212/NXI.0000000000000483. eCollection 2018 Sep. No abstract available.

13.

Bacterascites: A study of clinical features, microbiological findings, and clinical significance.

Oey RC, van Buuren HR, de Jong DM, Erler NS, de Man RA.

Liver Int. 2018 Jul 11. doi: 10.1111/liv.13929. [Epub ahead of print]

PMID:
29992711
14.

Involvement of MicroRNAs in the Aging-Related Decline of CD28 Expression by Human T Cells.

Teteloshvili N, Dekkema G, Boots AM, Heeringa P, Jellema P, de Jong D, Terpstra M, Brouwer E, Pawelec G, Kok K, van den Berg A, Kluiver J, Kroesen BJ.

Front Immunol. 2018 Jun 18;9:1400. doi: 10.3389/fimmu.2018.01400. eCollection 2018.

15.

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

Smits LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, de Jong DJ, Drenth JPH, Hoentjen F.

Inflamm Bowel Dis. 2018 Jun 27. doi: 10.1093/ibd/izy227. [Epub ahead of print]

PMID:
29947795
16.

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death.

Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, Brenner C, Ojcius DM, Kroemer G, Modjtahedi N, Deutsch E, Perfettini JL.

Cell Death Dis. 2018 Jun 18;9(7):716. doi: 10.1038/s41419-018-0747-y.

17.

Dynamic Regulation of Cerebral Blood Flow in Patients With Alzheimer Disease.

de Heus RAA, de Jong DLK, Sanders ML, van Spijker GJ, Oudegeest-Sander MH, Hopman MT, Lawlor BA, Olde Rikkert MGM, Claassen JAHR.

Hypertension. 2018 Jul;72(1):139-150. doi: 10.1161/HYPERTENSIONAHA.118.10900. Epub 2018 May 29.

PMID:
29844143
18.

Interobserver variation in CD30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment.

Koens L, van de Ven PM, Hijmering NJ, Kersten MJ, Diepstra A, Chamuleau M, de Jong D.

Histopathology. 2018 Sep;73(3):473-482. doi: 10.1111/his.13647. Epub 2018 Jun 26.

PMID:
29758590
19.

Investigation into the cellular origins of posterior regeneration in the annelid Capitella teleta.

de Jong DM, Seaver EC.

Regeneration (Oxf). 2017 Dec 6;5(1):61-77. doi: 10.1002/reg2.94. eCollection 2018 Mar.

20.

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.

PMID:
29514783
21.

Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells.

Dzikiewicz-Krawczyk A, Diepstra A, Rutgers B, Kortman G, de Jong D, Koerts J, Bulthuis M, van der Sluis T, Seitz A, Visser L, Kok K, Kluiver J, van den Berg A.

Am J Pathol. 2018 May;188(5):1289-1299. doi: 10.1016/j.ajpath.2018.01.018. Epub 2018 Feb 17.

PMID:
29458013
22.

Addition of simethicone improves small bowel capsule endoscopy visualisation quality.

Krijbolder MS, Grooteman KV, Bogers SK, de Jong DJ.

Neth J Med. 2018 Jan;76(1):27-31.

23.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
24.

Benign and malignant tumors in Rubinstein-Taybi syndrome.

Boot MV, van Belzen MJ, Overbeek LI, Hijmering N, Mendeville M, Waisfisz Q, Wesseling P, Hennekam RC, de Jong D.

Am J Med Genet A. 2018 Mar;176(3):597-608. doi: 10.1002/ajmg.a.38603. Epub 2018 Jan 23.

25.

Distorted Beliefs about Luck and Skill and Their Relation to Gambling Problems and Gambling Behavior in Dutch Gamblers.

Cowie ME, Stewart SH, Salmon J, Collins P, Al-Hamdani M, Boffo M, Salemink E, de Jong D, Smits R, Wiers RW.

Front Psychol. 2017 Dec 22;8:2245. doi: 10.3389/fpsyg.2017.02245. eCollection 2017.

26.

Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.

de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D.

JAMA Oncol. 2018 Mar 1;4(3):335-341. doi: 10.1001/jamaoncol.2017.4510.

PMID:
29302687
27.

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.

Spekhorst LM, Oldenburg B, van Bodegraven AA, de Jong DJ, Imhann F, van der Meulen-de Jong AE, Pierik MJ, van der Woude JC, Dijkstra G, D'Haens G, Löwenberg M, Weersma RK, Festen EAM; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

World J Gastroenterol. 2017 Dec 14;23(46):8182-8192. doi: 10.3748/wjg.v23.i46.8182.

28.

Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture.

de Wilde AH, Zevenhoven-Dobbe JC, Beugeling C, Chatterji U, de Jong D, Gallay P, Szuhai K, Posthuma CC, Snijder EJ.

Virology. 2018 Apr;517:148-156. doi: 10.1016/j.virol.2017.11.022. Epub 2017 Dec 15.

29.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, Beijert M, Hélias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1133-1145. doi: 10.1016/j.ijrobp.2017.10.015. Epub 2017 Oct 27.

PMID:
29229324
30.

Editorial: thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype-the perils of ageing. Authors' reply.

Broekman MMTJ, Wanten GJ, de Jong DJ.

Aliment Pharmacol Ther. 2018 Jan;47(1):130-131. doi: 10.1111/apt.14395. No abstract available.

PMID:
29226420
31.

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H.

Ann Hematol. 2018 Feb;97(2):255-266. doi: 10.1007/s00277-017-3167-7. Epub 2017 Dec 6.

32.

The NOD2 receptor is crucial for immune responses towards New World Leishmania species.

Dos Santos JC, Damen MSMA, Oosting M, de Jong DJ, Heinhuis B, Gomes RS, Araújo CS, Netea MG, Ribeiro-Dias F, Joosten LAB.

Sci Rep. 2017 Nov 9;7(1):15219. doi: 10.1038/s41598-017-15412-7.

33.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d'Haens G, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK; Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC).

BMJ Open. 2017 Nov 8;7(11):e016695. doi: 10.1136/bmjopen-2017-016695.

34.

Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases.

Broekman MMTJ, Coenen MJH, Wanten GJ, van Marrewijk CJ, Kievit W, Klungel OH, Verbeek ALM, Wong DR, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Bouvy ML, de Jong DJ.

Eur J Gastroenterol Hepatol. 2018 Feb;30(2):167-173. doi: 10.1097/MEG.0000000000001025.

35.

Luck, come here! Automatic approach tendencies toward gambling cues in moderate- to high-risk gamblers.

Boffo M, Smits R, Salmon JP, Cowie ME, de Jong DTHA, Salemink E, Collins P, Stewart SH, Wiers RW.

Addiction. 2018 Feb;113(2):289-298. doi: 10.1111/add.14071. Epub 2017 Nov 27.

PMID:
29055971
36.

Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.

de Boer M, van der Sluis WB, de Boer JP, Overbeek LIH, van Leeuwen FE, Rakhorst HA, van der Hulst RRWJ, Hijmering NJ, Bouman MB, de Jong D.

Aesthet Surg J. 2017 Sep 1;37(8):NP83-NP87. doi: 10.1093/asj/sjx098.

PMID:
29036941
37.

The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study.

Spekhorst LM, Severs M, de Boer NKH, Festen EAM, Fidder HH, Hoentjen F, Imhann F, de Jong DJ, van der Meulen-de Jong AE, Pierik MJ, van der Woude CJ, Dijkstra G, Ponsioen CY, Löwenberg M, Oldenburg B, Weersma RK; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2017 Dec 4;11(12):1463-1470. doi: 10.1093/ecco-jcc/jjx098.

PMID:
28981621
38.

Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.

Broekman MMTJ, Coenen MJH, Wanten GJ, van Marrewijk CJ, Klungel OH, Verbeek ALM, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Wong DR, de Jong DJ.

Aliment Pharmacol Ther. 2017 Nov;46(10):953-963. doi: 10.1111/apt.14323. Epub 2017 Sep 15.

39.

Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.

Severs M, Mangen MJ, Fidder HH, van der Valk ME, van der Have M, van Bodegraven AA, Clemens CHM, Dijkstra G, Jansen JM, de Jong DJ, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Pierik M, Ponsioen CY, Romberg-Camps MJL, Siersema PD, Jharap B, van der Woude JC, Zuithoff NPA, Oldenburg B.

Inflamm Bowel Dis. 2017 Sep;23(9):1568-1576. doi: 10.1097/MIB.0000000000001201.

PMID:
28700534
40.

Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease.

Smits LJT, Grelack A, Derikx LAAP, de Jong DJ, van Esch AAJ, Boshuizen RS, Drenth JPH, Hoentjen F.

Dig Dis Sci. 2017 Nov;62(11):3117-3122. doi: 10.1007/s10620-017-4661-4. Epub 2017 Jun 30.

41.

Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective study.

Bökkerink GMJ, van der Wilt GJ, de Jong D, van Krieken HHJM, Bleichrodt RP, de Wilt JHW, Bremers AJA.

World J Gastrointest Oncol. 2017 Jun 15;9(6):251-256. doi: 10.4251/wjgo.v9.i6.251.

42.

Entosis: The emerging face of non-cell-autonomous type IV programmed death.

Martins I, Raza SQ, Voisin L, Dakhli H, Law F, De Jong D, Allouch A, Thoreau M, Brenner C, Deutsch E, Perfettini JL.

Biomed J. 2017 Jun;40(3):133-140. doi: 10.1016/j.bj.2017.05.001. Epub 2017 May 31. Review.

43.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.

Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ; TOPIC Recruitment Team.

Inflamm Bowel Dis. 2017 Oct;23(10):1873-1881. doi: 10.1097/MIB.0000000000001163.

44.

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

Fermé C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, Lugtenburg PJ, Bouabdallah R, Carde P, Sebban C, Eghbali H, Salles G, van Imhoff GW, Thyss A, Noordijk EM, Reman O, Lybeert MLM, Janvier M, Spina M, Audhuy B, Raemaekers JMM, Delarue R, Anglaret B, de Weerdt O, Marjanovic Z, Tersteeg RJHA, de Jong D, Brière J, Henry-Amar M; European Organisation for Research and Treatment of Cancer Lymphoma Group, and; Groupe d'Étude des Lymphomes de l'Adulte.

Eur J Cancer. 2017 Aug;81:45-55. doi: 10.1016/j.ejca.2017.05.005. Epub 2017 Jun 8.

PMID:
28601705
45.

Lack of linear correlation between dynamic and steady-state cerebral autoregulation.

de Jong DLK, Tarumi T, Liu J, Zhang R, Claassen JAHR.

J Physiol. 2017 Aug 15;595(16):5623-5636. doi: 10.1113/JP274304. Epub 2017 Jul 14. Erratum in: J Physiol. 2018 Aug;596(16):3811.

46.

miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.

Yuan Y, Kluiver J, Koerts J, de Jong D, Rutgers B, Abdul Razak FR, Terpstra M, Plaat BE, Nolte IM, Diepstra A, Visser L, Kok K, van den Berg A.

Am J Pathol. 2017 Jun;187(6):1343-1355. doi: 10.1016/j.ajpath.2017.02.016. Epub 2017 Apr 20.

PMID:
28432871
47.

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

Stevens WBC, Mendeville M, Redd R, Clear AJ, Bladergroen R, Calaminici M, Rosenwald A, Hoster E, Hiddemann W, Gaulard P, Xerri L, Salles G, Klapper W, Pfreundschuh M, Jack A, Gascoyne RD, Natkunam Y, Advani R, Kimby E, Sander B, Sehn LH, Hagenbeek A, Raemaekers J, Gribben J, Kersten MJ, Ylstra B, Weller E, de Jong D.

Haematologica. 2017 Aug;102(8):1413-1423. doi: 10.3324/haematol.2017.165415. Epub 2017 Apr 14.

48.

B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.

de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):153-170. doi: 10.1093/ajcp/aqw216.

PMID:
28395108
49.

EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES.

Am J Clin Pathol. 2017 Feb 1;147(2):129-152. doi: 10.1093/ajcp/aqw214.

PMID:
28395107
50.

Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):204-216. doi: 10.1093/ajcp/aqw215.

PMID:
28395106

Supplemental Content

Loading ...
Support Center